Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.
Activated protein C (APC) plays a critical anticoagulant role in vivo by inactivating procoagulant factor Va and factor VIIIa and thus down-regulating thrombin generation. In addition, APC bound to the endothelial cell protein C receptor can initiate protease-activated receptor-1 (PAR-1)-mediated cytoprotective signaling. Protein S constitutes a critical cofactor for the anticoagulant function of APC but is not known to be involved in regulating APC-mediated protective PAR-1 signaling. In this study we utilized a site-directed mutagenesis strategy to characterize a putative protein S binding region within the APC Gla domain. Three single amino acid substitutions within the APC Gla domain (D35T, D36A, and A39V) were found to mildly impair protein S-dependent anticoagulant activity (<2-fold) but retained entirely normal cytoprotective activity. However, a single amino acid substitution (L38D) ablated the ability of protein S to function as a cofactor for this APC variant. Consequently, in assays of protein S-dependent factor Va proteolysis using purified proteins or in the plasma milieu, APC-L38D variant exhibited minimal residual anticoagulant activity compared with wild type APC. Despite the location of Leu-38 in the Gla domain, APC-L38D interacted normally with endothelial cell protein C receptor and retained its ability to trigger PAR-1 mediated cytoprotective signaling in a manner indistinguishable from that of wild type APC. Consequently, elimination of protein S cofactor enhancement of APC anticoagulant function represents a novel and effective strategy by which to separate the anticoagulant and cytoprotective functions of APC for potential therapeutic gain.
Harmon
Shona
S
Haemostasis Research Group, Institute of Molecular Medicine, St James's Hospital, Trinity College, Dublin 8, Ireland.
Preston
Roger J S
RJ
Ni Ainle
Fionnuala
F
Johnson
Jennifer A
JA
Cunningham
Moya S
MS
Smith
Owen P
OP
White
Barry
B
O'Donnell
James S
JS
D019943:Amino Acid Substitution; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D001665:Binding Sites / Q000235:genetics; D002460:Cell Line; D003067:Coenzymes / Q000235:genetics / Q000378:metabolism*; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D000074283:Endothelial Protein C Receptor; D015944:Factor VIIIa / Q000235:genetics / Q000378:metabolism; D015943:Factor Va / Q000235:genetics / Q000378:metabolism; D006801:Humans; D016297:Mutagenesis, Site-Directed; D010449:Peptide Mapping / Q000379:methods; D011486:Protein C / Q000235:genetics / Q000378:metabolism*; D017293:Protein S / Q000235:genetics / Q000378:metabolism*; D044463:Receptor, PAR-1 / Q000235:genetics / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D015703:Antigens, CD; D003067:Coenzymes; D000074283:Endothelial Protein C Receptor; C478370:PROCR protein, human; D011486:Protein C; D017293:Protein S; D044463:Receptor, PAR-1; D011956:Receptors, Cell Surface; D015943:Factor Va; D015944:Factor VIIIa
J Biol Chem. 1989 Mar 25;264(9):4743-6
2538457
J Biol Chem. 1998 Oct 16;273(42):27449-58
9765274
Blood. 2005 Apr 15;105(8):3178-84
15626732
Intensive Care Med. 2007 Mar;33(3):517-23
17325837
Thromb Haemost. 1999 Dec;82(6):1627-33
10613646
Br J Haematol. 2000 Jul;110(1):130-4
10930989
Blood. 2003 Feb 15;101(4):1416-8
12393507
Blood. 2005 Jan 1;105(1):122-30
15308562
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11
16488980
J Biol Chem. 2007 Mar 23;282(12):9251-9
17255099
Nature. 2008 Feb 28;451(7182):1076-81
18278032
Semin Thromb Hemost. 1984 Apr;10(2):131-8
6234659
Semin Hematol. 2002 Jul;39(3):197-205
12124682
J Biol Chem. 2001 Apr 6;276(14):11199-203
11278252
Biochim Biophys Acta. 1979 Dec 7;571(2):333-42
508770
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4423-8
12671072
FEBS J. 2005 Jan;272(1):97-108
15634335
N Engl J Med. 2001 Mar 8;344(10):699-709
11236773
J Biol Chem. 2006 Sep 29;281(39):28850-7
16867987
J Biol Chem. 1995 Sep 8;270(36):21158-66
7673148
Science. 2002 Jun 7;296(5574):1880-2
12052963
Eur J Biochem. 1995 Jan 15;227(1-2):433-40
7851419
J Biol Chem. 1990 May 15;265(14):8127-35
1692322
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10212-6
8816778
N Engl J Med. 1984 Mar 1;310(9):559-62
6546411
J Thromb Haemost. 2005 Dec;3(12):2798-805
16359518
Intensive Care Med. 2007 Mar;33(3):426-34
17325836
J Biol Chem. 1998 Apr 10;273(15):9031-40
9535891
JAMA. 2001 Oct 17;286(15):1869-78
11597289
Blood. 2004 Sep 15;104(6):1740-4
15178575
J Biol Chem. 1991 Oct 25;266(30):20139-45
1939075
Blood. 2003 Jun 15;101(12):4797-801
12586611
J Biol Chem. 2005 May 20;280(20):19808-14
15769747
J Biol Chem. 2007 Nov 9;282(45):33022-33
17872949
J Exp Med. 2007 Oct 1;204(10):2439-48
17893198
J Clin Invest. 2007 Jul;117(7):1951-60
17557119
J Biol Chem. 1999 Feb 26;274(9):5462-8
10026158
Nat Med. 2007 Nov;13(11):1349-58
17982464
J Thromb Haemost. 2006 Mar;4(3):704-6
16460467
Nat Med. 2003 Mar;9(3):338-42
12563316
Thromb Haemost. 1993 Jan 11;69(1):77-84
8446940